The study aims to identify clinical profiles of long-COVID patients and correlate themwith immunological and molecular data in order to identify prognostic biomarkers andpotential therapeutic targets.
Not Provided
Other: Blood sample collection
A one-time 30 mL blood draw is performed during the inclusion visit for immunological and
molecular analysis as part of the HERVCOV research program. No therapeutic intervention
is administered, and no samples are stored after analysis.
Inclusion Criteria:
- Documented SARS-CoV-2 infection
- Persistent or complex post-COVID symptoms lasting more than 4 weeks or more than 3
months
- Patient referred to the EPSILON pathway or to the post-COVID rehabilitation unit
- Age ≥ 18 years
- Non-institutionalized
- Expected survival greater than 6 months
Exclusion Criteria:
- Refusal to participate or to share data
- Uncontrolled comorbidities
- Pregnant or breastfeeding women
- Persons under legal protection or deprived of liberty
- Not affiliated with the French national health insurance system
Service Pneumologie aigue spécialisée et cancérologie thoracique
Pierre-Bénite, France
Hôpital Henry Gabrielle-HCL
Saint-Genis-Laval, France
Sébastien Couraud, Pr
04 78 86 44 01 - +33
Sebastien.couraud@chu-lyon.fr
Not Provided